Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_status_consensus
HLA-C	3107	broad.mit.edu	37	6	31239616	31239616	+	Missense_Mutation	SNP	C	C	A	rs150810080|rs1050445	byFrequency|by1000genomes	THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	g.chr6:31239616C>A	ENST00000383329.3	-	2	117	c.103G>T	c.(103-105)Gcc>Tcc	p.A35S	HLA-C_ENST00000376228.5_Missense_Mutation_p.A35S			Q9TNN7	1C05_HUMAN	major histocompatibility complex, class I, C	35	Alpha-1.	NA		NA	antigen processing and presentation of peptide antigen via MHC class I|interferon-gamma-mediated signaling pathway|interspecies interaction between organisms|regulation of immune response|type I interferon-mediated signaling pathway	integral to membrane|MHC class I protein complex				central_nervous_system(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(2)|lung(4)|prostate(4)|skin(2)|upper_aerodigestive_tract(1)	17						CGGGACACGGCGGTGTCGAAA	0.721		NA				NA		NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	18	18	18	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	31239616	NA	1475	2675	4150	SO:0001583	missense			ENSG00000204525	HGNC:4933	NM_002117	Approved	uc003nsy.3	NA	O02866|O62888|Q9TPV8|Q9TPX2	ENST00000383329.3	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	c|c	6.895|6.895	0.534735|0.534735	0.13188|0.13188	.|.	.|.	ENSG00000204525|ENSG00000204525	ENST00000376228;ENST00000383329;ENST00000396254;ENST00000539307|ENST00000415537	T;T|.	0.00966|.	5.49;5.49|.	2.16|2.16	-2.86|-2.86	0.05717|0.05717	MHC class I, alpha chain, alpha1/alpha2 (1);MHC classes I/II-like antigen recognition protein (1);MHC class I-like antigen recognition (1);|.	1.333240|.	0.06305|.	U|.	0.701534|.	T|T	0.15912|0.15912	0.0383|0.0383	L|L	0.48877|0.48877	1.53|1.53	0.80722|0.80722	P|P	0.0|0.0	B;B;B;B|.	0.06786|.	0.001;0.0;0.0;0.0|.	B;B;B;B|.	0.30105|.	0.111;0.069;0.069;0.069|.	T|T	0.23404|0.23404	-1.0189|-1.0189	9|4	0.02654|.	T|.	1|.	.|.	4.1764|4.1764	0.10353|0.10353	0.5673:0.2969:0.0:0.1358|0.5673:0.2969:0.0:0.1358	rs1050445;rs3190759;rs3190813;rs17413569|rs1050445;rs3190759;rs3190813;rs17413569	35;35;35;35|.	A2AEA4;A6H578;A2AEA2;P10321|.	.;.;.;1C07_HUMAN|.	S|L	35;35;35;72|34	ENSP00000365402:A35S;ENSP00000372819:A35S|.	ENSP00000365402:A35S|.	A|R	-|-	1|2	0|0	HLA-C|HLA-C	31347595|31347595	0.000000|0.000000	0.05858|0.05858	0.013000|0.013000	0.15412|0.15412	0.003000|0.003000	0.03518|0.03518	-2.010000|-2.010000	0.01454|0.01454	-0.823000|-0.823000	0.04301|0.04301	-0.680000|-0.680000	0.03767|0.03767	GCC|CGC	HLA-C-002	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000258079.1	0.768822	KEEP	NA	-	7.678361	0.095238	4	38	---	---	---	---	1	0.9750081	1938	5269	1	63	4	44	1	63	274	TP
AK9	221264	broad.mit.edu	37	6	109954219	109954219	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	g.chr6:109954219C>T	ENST00000424296.2	-	12	1237	c.1161G>A	c.(1159-1161)atG>atA	p.M387I	AK9_ENST00000285397.5_Missense_Mutation_p.M387I|AK9_ENST00000341338.6_5'UTR|AK9_ENST00000368948.2_Missense_Mutation_p.M387I	NM_001145128.2	NP_001138600.2			adenylate kinase 9	NA		NA		NA							NA						GTGGTCCTGGCATAGGTGGAA	0.373		NA				NA		NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	139	128	132	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	109954219	NA	2203	4300	6503	SO:0001583	missense				HGNC:33814	NM_001145128	Approved		NA		ENST00000424296.2	37	CCDS55048.1	.	.	.	.	.	.	.	.	.	.	C	22.1	4.249544	0.80024	.	.	ENSG00000155085	ENST00000424296;ENST00000368948;ENST00000285397	T;T;T	0.64991	-0.13;-0.08;2.69	5.6	5.6	0.85130	.	0.037370	0.85682	D	0.000000	T	0.35508	0.0934	N	0.04768	-0.165	0.80722	D	1	P;B	0.49307	0.922;0.327	P;B	0.45610	0.487;0.394	T	0.32241	-0.9914	9	.	.	.	-18.7395	19.5908	0.95509	0.0:1.0:0.0:0.0	.	387;387	Q5TCS8-2;Q5TCS8	.;AKD1_HUMAN	I	387	ENSP00000410186:M387I;ENSP00000357944:M387I;ENSP00000285397:M387I	.	M	-	3	0	AKD1	110060912	1.000000	0.71417	1.000000	0.80357	0.859000	0.49053	5.412000	0.66392	2.628000	0.89032	0.467000	0.42956	ATG	AK9-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		31.953841	KEEP	NA	-	34.115026	0.28	14	36	---	---	---	---	1	0.9495467	5	7	0	72	17	44	0	72	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	112	104	107	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	140453136	NA	2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	29.615807	KEEP	NA	-	34.281928	0.21875	14	50	---	---	---	---	1	0.8851756	5	12	0	94	15	57	0	94	2	TP
TCF7L2	6934	broad.mit.edu	37	10	114903693	114903693	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	g.chr10:114903693C>T	ENST00000355995.4	+	7	1204	c.697C>T	c.(697-699)Cct>Tct	p.P233S	TCF7L2_ENST00000534894.1_Missense_Mutation_p.P233S|TCF7L2_ENST00000538897.1_Missense_Mutation_p.P233S|TCF7L2_ENST00000543371.1_Missense_Mutation_p.P233S|TCF7L2_ENST00000369395.1_Missense_Mutation_p.P258S|TCF7L2_ENST00000536810.1_Missense_Mutation_p.P233S|TCF7L2_ENST00000542695.1_5'UTR|TCF7L2_ENST00000369389.1_5'UTR|TCF7L2_ENST00000349937.2_Missense_Mutation_p.P233S|TCF7L2_ENST00000355717.4_Missense_Mutation_p.P257S|TCF7L2_ENST00000369397.4_Missense_Mutation_p.P210S|TCF7L2_ENST00000352065.5_Missense_Mutation_p.P210S|TCF7L2_ENST00000545257.1_Missense_Mutation_p.P233S			Q9NQB0	TF7L2_HUMAN	transcription factor 7-like 2 (T-cell specific, HMG-box)	233	Mediates interaction with MAD2L2.|Pro-rich.	NA		NA	anti-apoptosis|blood vessel development|canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition|cell cycle arrest|cell proliferation|fat cell differentiation|glucose homeostasis|maintenance of DNA repeat elements|myoblast cell fate commitment|negative regulation of canonical Wnt receptor signaling pathway|negative regulation of sequence-specific DNA binding transcription factor activity|negative regulation of transcription from RNA polymerase II promoter|pancreas development|positive regulation of heparan sulfate proteoglycan biosynthetic process|positive regulation of insulin secretion|positive regulation of protein binding|positive regulation of protein export from nucleus|positive regulation of protein kinase B signaling cascade|positive regulation of transcription from RNA polymerase II promoter|regulation of hormone metabolic process|regulation of smooth muscle cell proliferation|response to glucose stimulus	beta-catenin-TCF7L2 complex|PML body|protein-DNA complex	armadillo repeat domain binding|beta-catenin binding|gamma-catenin binding|nuclear hormone receptor binding|protein kinase binding|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|transcription factor binding|transcription regulatory region DNA binding		VTI1A/TCF7L2(8)	central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(24)|liver(2)|lung(8)|ovary(1)|skin(1)	41		Breast(234;0.058)|Colorectal(252;0.0615)		Epithelial(162;0.00554)|all cancers(201;0.02)		AATCCCACGGCCTCCGCACCC	0.522		NA	T	VTI1A	colorectal	NA		NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	Dom	yes	NA	10	10q25.3	6934	transcription factor 7-like 2		E	0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	79	67	71	NA	NA	NA	NA	10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	114903693	NA	2203	4300	6503	SO:0001583	missense			ENSG00000148737	HGNC:11641	NM_030756	Approved	uc001lae.4	NA	O00185|Q9NQB1|Q9NQB2|Q9NQB3|Q9NQB4|Q9NQB5|Q9NQB6|Q9NQB7|Q9ULC2	ENST00000355995.4	37		.	.	.	.	.	.	.	.	.	.	c	23.1	4.369547	0.82463	.	.	ENSG00000148737	ENST00000355995;ENST00000545257;ENST00000543371;ENST00000536810;ENST00000355717;ENST00000538897;ENST00000534894;ENST00000369397;ENST00000349937;ENST00000352065;ENST00000369395	D;D;D;D;D;D;D;D;D	0.99207	-5.0;-5.0;-5.0;-5.01;-5.53;-5.56;-5.54;-5.0;-5.54	5.26	4.35	0.52113	CTNNB1 binding, N-teminal (1);	0.110472	0.64402	D	0.000007	D	0.99202	0.9723	M	0.61703	1.905	0.80722	D	1	B;D;B;P;P;P;D;D;D;B;P;P;B;D;D;D;B;B;P	0.89917	0.071;0.974;0.41;0.869;0.933;0.87;0.994;0.964;0.971;0.051;0.941;0.621;0.447;1.0;0.999;0.971;0.117;0.393;0.629	B;P;B;P;P;P;D;P;P;B;P;P;B;D;D;P;B;B;P	0.87578	0.089;0.88;0.349;0.796;0.796;0.593;0.912;0.79;0.739;0.088;0.855;0.593;0.439;0.993;0.998;0.796;0.343;0.406;0.542	D	0.99406	1.0929	10	0.59425	D	0.04	-9.0972	16.1275	0.81404	0.0:0.866:0.134:0.0	.	90;50;127;233;104;152;210;210;210;176;233;210;210;210;257;210;233;210;210	B4DJZ2;B7Z9Z6;B4DWD5;Q9NQB0;C6ZRK4;C6ZRJ6;C6ZRJ9;F8W742;B4DRJ8;C6ZRK2;B9X074;C6ZRJ8;C6ZRK1;C6ZRJ7;F8W7T5;C6ZRK5;Q9NQB0-7;Q9NQB0-10;Q6FHW4	.;.;.;TF7L2_HUMAN;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.	S	233;233;233;233;257;233;233;210;233;210;258	ENSP00000348274:P233S;ENSP00000440547:P233S;ENSP00000444972:P233S;ENSP00000446238:P233S;ENSP00000347949:P257S;ENSP00000446172:P233S;ENSP00000443626:P233S;ENSP00000358404:P210S;ENSP00000344823:P210S	ENSP00000298692:P233S	P	+	1	0	TCF7L2	114893683	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	6.028000	0.70889	1.330000	0.45394	0.655000	0.94253	CCT	TCF7L2-203	KNOWN	basic	protein_coding	NA	protein_coding		35.700991	KEEP	NA	+	37.943637	0.283019	15	38	---	---	---	---	1	0.9979602	8	24	0	80	17	47	0	80	2	TP
PRPF8	10594	broad.mit.edu	37	17	1564035	1564035	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	g.chr17:1564035C>T	ENST00000572621.1	-	28	4860	c.4595G>A	c.(4594-4596)cGt>cAt	p.R1532H	PRPF8_ENST00000304992.6_Missense_Mutation_p.R1532H			Q6P2Q9	PRP8_HUMAN	pre-mRNA processing factor 8	1532		NA		NA		catalytic step 2 spliceosome|nuclear speck|U5 snRNP	protein binding|RNA binding			NS(1)|autonomic_ganglia(1)|breast(2)|endometrium(11)|haematopoietic_and_lymphoid_tissue(3)|kidney(8)|large_intestine(13)|lung(24)|ovary(2)|prostate(2)|skin(2)|upper_aerodigestive_tract(5)|urinary_tract(3)	77				UCEC - Uterine corpus endometrioid carcinoma (25;0.0855)		GGTGAATCTACGATTGGGAAT	0.502		NA				NA		NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	123	127	NA	NA	NA	NA	17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1564035	NA	2203	4300	6503	SO:0001583	missense			ENSG00000174231	HGNC:17340		Approved	uc002fte.3	NA	O14547|O75965	ENST00000572621.1	37	CCDS11010.1	.	.	.	.	.	.	.	.	.	.	c	30	5.051892	0.93793	.	.	ENSG00000174231	ENST00000304992;ENST00000540177	D	0.84873	-1.91	6.17	6.17	0.99709	Pre-mRNA-processing-splicing factor 8, U6-snRNA-binding (1);	0.000000	0.85682	D	0.000000	D	0.94105	0.8110	M	0.88105	2.93	0.80722	D	1	D	0.89917	1.0	D	0.76575	0.988	D	0.93932	0.7215	10	0.87932	D	0	.	20.8794	0.99867	0.0:1.0:0.0:0.0	.	1532	Q6P2Q9	PRP8_HUMAN	H	1532;59	ENSP00000304350:R1532H	ENSP00000304350:R1532H	R	-	2	0	PRPF8	1510785	1.000000	0.71417	1.000000	0.80357	0.987000	0.75469	5.935000	0.70145	2.941000	0.99782	0.655000	0.94253	CGT	PRPF8-002	NOVEL	alternative_5_UTR|not_organism_supported|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000438412.2	-0.873788	KEEP	NA	-	10.769994	0.078125	5	59	---	---	---	---	1	0.9958721	5	145	0	113	5	62	0	113	2	TP
TXNL1	9352	broad.mit.edu	37	18	54293600	54293600	+	Nonsense_Mutation	SNP	G	G	A			THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	g.chr18:54293600G>A	ENST00000217515.6	-	2	391	c.187C>T	c.(187-189)Cag>Tag	p.Q63*	TXNL1_ENST00000590954.1_Nonsense_Mutation_p.Q63*|TXNL1_ENST00000540155.1_5'UTR	NM_004786.2	NP_004777.1	O43396	TXNL1_HUMAN	thioredoxin-like 1	63	Thioredoxin.	NA		NA	cell redox homeostasis|electron transport chain|glycerol ether metabolic process|transport	cytoplasm	electron carrier activity|protein disulfide oxidoreductase activity			endometrium(1)|large_intestine(1)|lung(1)|urinary_tract(1)	4				READ - Rectum adenocarcinoma(59;0.193)|Colorectal(16;0.211)		ACCTGACACTGATGTACATCG	0.343		NA				NA		NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	128	134	132	NA	NA	NA	NA	18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	54293600	NA	2203	4300	6503	SO:0001587	stop_gained			ENSG00000091164	HGNC:12436		Approved	uc002lgg.3	NA		ENST00000217515.6	37	CCDS11961.1	.	.	.	.	.	.	.	.	.	.	G	37	6.504314	0.97620	.	.	ENSG00000091164	ENST00000217515	.	.	.	5.56	4.68	0.58851	.	0.228496	0.45606	D	0.000347	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	.	15.9832	0.80127	0.0:0.1354:0.8646:0.0	.	.	.	.	X	63	.	ENSP00000217515:Q63X	Q	-	1	0	TXNL1	52444598	1.000000	0.71417	1.000000	0.80357	0.831000	0.47069	6.696000	0.74598	1.328000	0.45358	0.655000	0.94253	CAG	TXNL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256064.2	-14.684346	KEEP	NA	-	10.190631	0.057851	7	114	---	---	---	---	1	0.9999965	14	534	0	158	8	129	0	158	2	TP
ZNF440	126070	broad.mit.edu	37	19	11944507	11944507	+	3'UTR	SNP	C	C	T			THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-BJ-A45H-Tumor-SM-3O9RY	THCA-TCGA-BJ-A45H-Normal-SM-3O9S3	g.chr19:11944507C>T	ENST00000304060.5	+	0	2680					NM_152357.2	NP_689570.2	Q8IYI8	ZN440_HUMAN	zinc finger protein 440	NA		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(3)|endometrium(4)|kidney(1)|large_intestine(7)|lung(9)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	27						TTCATTTCTTCTAGTTCCCTT	0.418		NA				NA		NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000171295	HGNC:20874	NM_152357	Approved	uc002msp.1	NA	Q8N1R9	ENST00000304060.5	37	CCDS42503.1																																																																																			ZNF440-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000344508.1	8.055238	KEEP	NA	+	11.217568	0.166667	5	25	---	---	---	---	1	0.3024699	2	4	0	31	5	26	0	31	2	TP
